| Dr Michael John Cipolla, MD | |
|
3670 South Benzing Rd, Suite C, Orchard Park, NY 14127 | |
| (716) 675-5711 | |
| (716) 675-1358 |
| Full Name | Dr Michael John Cipolla |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 16 Years |
| Location | 3670 South Benzing Rd, Orchard Park, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841450137 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 265808-1 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Western New York Ear, Nose And Throat, P.c. | 5193762235 | 9 |
News Archive
Claims about the health benefits of foods and nutritional supplements have proliferated in recent years, most of them based on studies measuring ingredients' effects on biomarkers as substitutes for actual clinical outcomes.
BioAlliance Pharma SA (Paris:BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announced that the U.S. Food and Drug Administration (FDA) has accepted the new drug application (NDA) for miconazole Lauriad® (Loramyc®) Mucoadhesive Buccal Tablets (MBT) to treat oropharyngeal candidiasis (OPC). Miconazole Lauriad® delivers the antifungal miconazole via a mucoadhesive buccal tablet that is designed to enable once-daily dosing of the active ingredient at the site of infection.
DataMetrix's newly released technology platform, CASE™, provides the industry with the ability to audit claims for payment accuracy through the integration of a fully automated rules engine with sub-second response capability and a proprietary format which triages claims targeted for in-depth clinical review.
Braeburn Pharmaceuticals, an Apple Tree Partners company, today reported positive topline results from the Phase 3 double-blind, double-dummy clinical study of Probuphine, the investigational subdermal implant containing buprenorphine HCl for the long-term maintenance treatment of opioid addiction.
› Verified 1 days ago
| Entity Name | Western New York Ear, Nose & Throat, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487877817 PECOS PAC ID: 5193762235 Enrollment ID: O20050411001028 |
News Archive
Claims about the health benefits of foods and nutritional supplements have proliferated in recent years, most of them based on studies measuring ingredients' effects on biomarkers as substitutes for actual clinical outcomes.
BioAlliance Pharma SA (Paris:BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announced that the U.S. Food and Drug Administration (FDA) has accepted the new drug application (NDA) for miconazole Lauriad® (Loramyc®) Mucoadhesive Buccal Tablets (MBT) to treat oropharyngeal candidiasis (OPC). Miconazole Lauriad® delivers the antifungal miconazole via a mucoadhesive buccal tablet that is designed to enable once-daily dosing of the active ingredient at the site of infection.
DataMetrix's newly released technology platform, CASE™, provides the industry with the ability to audit claims for payment accuracy through the integration of a fully automated rules engine with sub-second response capability and a proprietary format which triages claims targeted for in-depth clinical review.
Braeburn Pharmaceuticals, an Apple Tree Partners company, today reported positive topline results from the Phase 3 double-blind, double-dummy clinical study of Probuphine, the investigational subdermal implant containing buprenorphine HCl for the long-term maintenance treatment of opioid addiction.
› Verified 1 days ago
| Entity Name | Southtowns Surgery Center Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1518323435 PECOS PAC ID: 4789983479 Enrollment ID: O20160502001374 |
News Archive
Claims about the health benefits of foods and nutritional supplements have proliferated in recent years, most of them based on studies measuring ingredients' effects on biomarkers as substitutes for actual clinical outcomes.
BioAlliance Pharma SA (Paris:BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announced that the U.S. Food and Drug Administration (FDA) has accepted the new drug application (NDA) for miconazole Lauriad® (Loramyc®) Mucoadhesive Buccal Tablets (MBT) to treat oropharyngeal candidiasis (OPC). Miconazole Lauriad® delivers the antifungal miconazole via a mucoadhesive buccal tablet that is designed to enable once-daily dosing of the active ingredient at the site of infection.
DataMetrix's newly released technology platform, CASE™, provides the industry with the ability to audit claims for payment accuracy through the integration of a fully automated rules engine with sub-second response capability and a proprietary format which triages claims targeted for in-depth clinical review.
Braeburn Pharmaceuticals, an Apple Tree Partners company, today reported positive topline results from the Phase 3 double-blind, double-dummy clinical study of Probuphine, the investigational subdermal implant containing buprenorphine HCl for the long-term maintenance treatment of opioid addiction.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael John Cipolla, MD 3670 South Benzing Rd, Suite C, Orchard Park, NY 14127 Ph: (716) 675-5711 | Dr Michael John Cipolla, MD 3670 South Benzing Rd, Suite C, Orchard Park, NY 14127 Ph: (716) 675-5711 |
News Archive
Claims about the health benefits of foods and nutritional supplements have proliferated in recent years, most of them based on studies measuring ingredients' effects on biomarkers as substitutes for actual clinical outcomes.
BioAlliance Pharma SA (Paris:BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announced that the U.S. Food and Drug Administration (FDA) has accepted the new drug application (NDA) for miconazole Lauriad® (Loramyc®) Mucoadhesive Buccal Tablets (MBT) to treat oropharyngeal candidiasis (OPC). Miconazole Lauriad® delivers the antifungal miconazole via a mucoadhesive buccal tablet that is designed to enable once-daily dosing of the active ingredient at the site of infection.
DataMetrix's newly released technology platform, CASE™, provides the industry with the ability to audit claims for payment accuracy through the integration of a fully automated rules engine with sub-second response capability and a proprietary format which triages claims targeted for in-depth clinical review.
Braeburn Pharmaceuticals, an Apple Tree Partners company, today reported positive topline results from the Phase 3 double-blind, double-dummy clinical study of Probuphine, the investigational subdermal implant containing buprenorphine HCl for the long-term maintenance treatment of opioid addiction.
› Verified 1 days ago
Dr. James M Poss, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 3900 N Buffalo St, Orchard Park, NY 14127 Phone: 716-823-4962 Fax: 716-823-4962 | |
Dr. Alexander Kendrat Mandych, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3075 Southwestern Blvd, Suite 102, Orchard Park, NY 14127 Phone: 716-675-0616 Fax: 716-675-7101 | |
Dr. Jonathan Charles Vogan, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3075 Southwestern Blvd, Suite 102, Orchard Park, NY 14127 Phone: 716-675-0616 Fax: 716-675-7101 | |
Dr. Natalka Daria Stachiw, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3670 South Benzing Rd, Suite C, Orchard Park, NY 14127 Phone: 716-675-5711 Fax: 716-675-1358 | |
Frederick Carlton Gass, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3075 Southwestern Blvd, Suite 102, Orchard Park, NY 14127 Phone: 716-675-0616 Fax: 716-675-7101 | |
Heather Fenley Crabtree, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3670 S Benzing Rd Ste C, Orchard Park, NY 14127 Phone: 215-300-2577 |